# Kite Pharma, Inc. – FDA Inspection, Aug 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/6c854143-66e4-4bfa-b0da-a4e4e9b83d60
Source feed: FDA_Inspections

> FDA inspection 1279894 of Kite Pharma, Inc., August 27, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279894
- Company Name: Kite Pharma, Inc.
- Inspection Date: 2025-08-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1155166 - 2021-10-22
- [FDA Inspection 1100058 - 2019-08-20](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/76901832-4400-44b6-9915-b8aa6c598211)
- [FDA Inspection 1015808 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/edd81dfc-f202-4cbe-8592-4d5b2bf6e545)

## Related Officers

- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)
- [FDA Associated Person](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)

Company: https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
